Edesa Biotech, Inc. (EDSA)
6.23
-0.34
(-5.18%)
USD |
NASDAQ |
Mar 26, 14:28
Edesa Biotech Free Cash Flow : -8.004M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Oncolytics Biotech, Inc. | -18.79M |
| Aurinia Pharmaceuticals, Inc. | 135.69M |
| Lexaria Bioscience Corp. | -8.775M |
| Xenon Pharmaceuticals, Inc. | -280.51M |
| ProMIS Neurosciences, Inc. | -27.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.087M |
| Cash from Financing (Quarterly) | 3.355M |
| Free Cash Flow Per Share (Quarterly) | -0.2618 |
| Free Cash Flow to Equity (Quarterly) | -2.087M |
| Free Cash Flow to Firm (Quarterly) | -2.087M |
| Free Cash Flow Yield | -18.78% |